Bibliography

• Predictors of clinically relevant bleeding during extended anticoagulation for cancer-associated venous thromboembolism (API-CAT): a post-hoc analysis of a randomised, non-inferiority trial

Isabelle Mahé 1, Céline Chapelle 2, Philippe Girard 3, Marc Carrier 4, Luis Jara Palomares 5, Charles-Marc Samama 6, Hélène Helfer 7, Grigoris Gerotziafas 8, Silvy Laporte 9, Eric Vicaut 10, Patrick Mismetti 11; API-CAT Study Group; API-CAT Investigators

PMID: 41365312 DOI: 10.1016/S2352-3026(25)00291-1

• Venous Thromboembolism at Low Risk of Recurrence in Young Women: Stress and Violence Associated with Recurrence. An International Case-Control Study

Victoria Bitsadze, Mariya Gennadevna Nikolaeva, Ève Mousty, Jamilya Khizroeva, Jérémy Laurent, Sylvie Ripart, Ekaterina Kudryavtseva, Lorris Le Collen, Anastasia Shatilina, Salim Allal, Elizaveta Lyadnova, Mathieu Fortier, Sylvie Bouvier, Mathias Chea, Marina Sabirovna Zainulina, Antonia Perez-Martin, Alexander Makatsariya , Jean-Christophe GrisObservational Study. Thromb Haemost. 2025 Jul;125(7):643-656. PMID: 39694062 DOI: 10.1055/a-2484-0923

• Venous thromboembolism associated with weak transient risk factors in young women: risk of late recurrence. An international cohort study

Victoria Bitsadze, Mariya Gennadevna Nikolaeva, Eve Mousty, Jamilya Khizroeva, Jeremy Laurent, Sylvie Ripart , Lorris Le Collen, Salim Allal, Mathieu Fortier, Sylvie Bouvier, Mathias Chea, Antonia Perez-Martin, Alexander Makatsariya , Jean-Christophe Gris. Observational Study. Eur J Intern Med. 2025 Dec:142:106410. PMID: 40653393 DOI: 10.1016/j.ejim.2025.07.006

• Tinzaparin Pharmacokinetics in Patients with Cancer: A Comparative Modeling Study

Xavier Delavenne, Jean Escal, Dominique Helley, Laurent Bertoletti, Nicolas Falvo, Isabelle Mahé, Benjamin Crichi, Francis Couturaud, Marie-Antoinette Sevestre, Michel Pavic, Laetitia Mauge, Sara Zia-Chahabi, Aurélie Vilfaillot, Juliette Djadi-Prat, Patrick Mismetti, Guy Meyer, Olivier Sanchez. PMID: 41290197 DOI: 10.1055/a-2740-1841

• Extended Reduced-Dose Apixaban for Cancer-Associated Venous Thromboembolism.

Mahé I, Carrier M, Mayeur D, Chidiac J, Vicaut E, Falvo N, Sanchez O, Grange C, Monreal M, López-Núñez JJ, Otero-Candelera R, Le Gal G, Yeo E, Righini M, Robert-Ebadi H, Huisman MV, Klok FA, Westerweel P, Agnelli G, Becattini C, Bamias A, Syrigos K, Szmit S, Torbicki A, Verhamme P, Maraveyas A, Cohen AT, Ay C, Chapelle C, Meyer G, Couturaud F, Mismetti P, Girard P, Bertoletti L, Laporte S; API-CAT Investigators. N Engl J Med. 2025 Apr 10;392(14):1363-1373. doi: 10.1056/NEJMoa2416112. Epub 2025 Mar 29. PMID: 40162636 Clinical Trial.

• Extended treatment of venous thromboembolism with reduced-dose versus full-dose direct oral anticoagulants in patients at high risk of recurrence: a non-inferiority, multicentre, randomised, open-label, blinded endpoint trial.

Couturaud F, Schmidt J, Sanchez O, Ballerie A, Sevestre MA, Meneveau N, Bertoletti L, Connault J, Benhamou Y, Constans J, Quemeneur T, Lapébie FX, Pernod G, Picart G, Elias A, Doutrelon C, Neveux C, Khider L, Roy PM, Zuily S, Falvo N, Lacroix P, Emmerich J, Mahé I, Boileau J, Yaici A, Le Jeune S, Stéphan D, Plissonneau-Duquene P, Ray V, des Déserts MD, Belhadj-Chaidi R, Lamia B, Gruel Y, Presles E, Girard P, Tromeur C, Moustafa F, Rothstein V, Lacut K, Melac S, Barillot S, Mismetti P, Laporte S, Mottier D, Meyer G, Leroyer C; RENOVE Investigators. Lancet. 2025 Mar 1;405(10480):725-735. doi: 10.1016/S0140-6736(24)02842-3. PMID: 40023651 Free article. Clinical Trial.

• Carbon footprint of direct oral anticoagulants in atrial fibrillation and venous thromboembolism.

Chery L, Hassani Z, Durand L, Boisseau D, Monguillon V, Grimaldi D, Taillemite S, Marie BS, Gendron N. Haematologica. 2025 Dec 11. doi: 10.3324/haematol.2025.300204. Online ahead of print. PMID: 41376576 Free article.

• Usefulness and Limits of DOAC Removal Agents Based on Activated Charcoal in Thrombophilia Testing: Literature Review and Expert Proposals.

Jourdi G, Flaujac C, De Maistre E, Gendron N, Eschwège V, Mauge L; French Society on Thrombosis Haemostasis. Thromb Haemost. 2025 Sep 29. doi: 10.1055/a-2695-2674. Online ahead of print. PMID: 41022132

• Predictive factors for complete recovery of post-thrombotic syndrome 6 months after venous recanalization.

Khider L, Del Giudice C, Gendron N, Gobert C, Planquette B, Al Ahmar M, Goudot G, Messas E, Sapoval M, Mirault T. J Vasc Surg Venous Lymphat Disord. 2025 Nov;13(6):102287. doi: 10.1016/j.jvsv.2025.102287. Epub 2025 Jul 11. PMID: 40653089 Free PMC article.

• How to Manage Venous Thromboembolism Risk during Pregnancy in Patients with Inherited Antithrombin Deficiency?

Mauge L, Madar H, Carré J, Fiore M, Gendron N, Mouton C, Proulle V, Suchon P, Trillot N, Lechat T, Sentilhes L, Macchi L; TITAN group of the French Society of Thrombosis and Haemostasis (SFTH). Thromb Haemost. 2025 Jul 24. doi: 10.1055/a-2650-7959. Online ahead of print. PMID: 40628415

• Pharmacists' Knowledge of Abnormal Uterine Bleeding in Women on Anticoagulant Therapy: A French Survey.

Frerebeau S, Planquette B, Sarlon G, Gendron N.

Clin Appl Thromb Hemost. 2025 Jan-Dec;31:10760296251350078. doi: 10.1177/10760296251350078. Epub 2025 Jun 17.

PMID: 40525254 Free PMC article.

• Relevance of anti-platelet factor 4/heparin antibodies and platelet activation in systemic inflammatory diseases and thrombosis disorders: insight from the COVID-19 pandemic.

Gendron N, Helley D, Thaler J, Faille D, Le Beller C, Gruest M, Hadjadj J, Philippe A, Zeco F, Courbebaisse M, Darnige L, Amara W, Calmette L, Parfait B, Auditeau C, Chocron R, Khider L, Mauge L, Espitia O, Friedlander G, Ajzenberg N, Lebeaux D, Planquette B, Sanchez O, Diehl JL; COVID-HOP Study Group; Lillo-Le Louet A, Terrier B, Smadja DM. Res Pract Thromb Haemost. 2025 Feb 9;9(1):102701. doi: 10.1016/j.rpth.2025.102701. eCollection 2025 Jan.

PMID: 40123654 Free PMC article.

• Circulating CD34+ Cells: A New Biomarker of Residual Pulmonary Vascular Obstruction after Pulmonary Embolism.

Gendron N, Planquette B, Roche A, Chocron R, Helley D, Philippe A, Morange PE, Gaussem P, Sanchez O, Smadja DM. Stem Cell Rev Rep. 2025 Jun;21(5):1501-1511. doi: 10.1007/s12015-025-10865-0. Epub 2025 Mar 14. PMID: 40085375

• How to deal with interference on heparin anti-Xa activity caused by oral factor FXa inhibitors: communication from the ISTH SSC Subcommittee on Control of Anticoagulation.

Gendron N, Cuker A, Gosselin RC, Castellucci LA, Thachil J. J Thromb Haemost. 2025 Jun;23(6):2060-2066. doi: 10.1016/j.jtha.2025.02.026. Epub 2025 Mar 7. PMID: 40056991

• VITT-like Monoclonal Gammopathy of Thrombotic Significance.

Wang JJ, Warkentin TE, Schönborn L, Wheeler MB, Geerts WH, Costedoat-Chalumeau N, Gendron N, Ene G, Lozano M, Langer F, Lindhoff-Last E, Budde K, Chataway T, Troelnikov A, Sheppard JI, Zhang Y, Arnold DM, Gordon TP, Thiele T, Greinacher A, Nazy I.

N Engl J Med. 2025 Mar 6;392(10):995-1005. doi: 10.1056/NEJMoa2415930. Epub 2025 Feb 12. PMID: 39938091

• Should a history of venous thromboembolism be considered a contraindication for scuba diving?

Vannini M, Schved JF, Smadja DM, Jung VEM, Mauge L, Sanchez O, Gendron N. Res Pract Thromb Haemost. 2024 Dec 2;9(1):102647. doi: 10.1016/j.rpth.2024.102647. eCollection 2025 Jan. PMID: 39810982

• Intimate partner violence as a risk factor for venous thromboembolism in women on combined oral contraceptives: An international matched case-control study

Mathias Chéa, Chloé Bourguignon, Sylvie Bouvier, Eva Nouvellon, Jeremy Laurent, Antonia Perez-Martin, Eve Mousty, Sylvie Ripart, Mariya Gennadevna Nikolaeva, Jamilya Khizroeva, Victoria Bitsadze, Alexander Makatsariya, Jean-Christophe Gris

Eur J Intern Med. 2024 Apr:122:47-53. PMID: 38135584 DOI: 10.1016/j.ejim.2023.12.016